KBIO LABS Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 929.00
+2.00 (0.22%)
At close: Jun 17, 2026
KBIO LABS Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2,340 | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 |
Depreciation & Amortization | 944.5 | 937.55 | 1,084 | 491.03 | 591.58 | 674 |
Loss (Gain) From Sale of Assets | -2.73 | -4.48 | -0.79 | 26.74 | 138.77 | -170.06 |
Asset Writedown & Restructuring Costs | 12.01 | 12.01 | 3,890 | - | 54.46 | 2,261 |
Loss (Gain) From Sale of Investments | -255.24 | 1,576 | 1,557 | 1,203 | 1,196 | -183.48 |
Loss (Gain) on Equity Investments | 4,712 | 5,518 | 6,263 | 27,097 | 4,561 | 11,053 |
Provision & Write-off of Bad Debts | 52.67 | 92.07 | 218.14 | -76.49 | -427.28 | 545.95 |
Other Operating Activities | 184.96 | -215.94 | -1,548 | -15,800 | 2,103 | 2,191 |
Change in Accounts Receivable | 4,191 | -1,950 | -512.25 | -25.9 | 1,456 | 1,407 |
Change in Inventory | 1,034 | -1,408 | -1,026 | -1,649 | 731.89 | 1,102 |
Change in Accounts Payable | -1,760 | 4,643 | -361.09 | 374.89 | 160.42 | -1,864 |
Change in Other Net Operating Assets | 1,166 | 2,195 | -2,893 | -430.48 | 883.46 | 1,331 |
Operating Cash Flow | 7,938 | 8,196 | -119.17 | -1,463 | 3,784 | -1,120 |
Capital Expenditures | -28.22 | -35.84 | -71.16 | -7.95 | -15.63 | -93.37 |
Sale of Property, Plant & Equipment | 2.73 | 6.36 | 1.98 | - | 43.06 | 1,328 |
Cash Acquisitions | - | - | -2,496 | - | - | - |
Divestitures | - | - | - | 38,157 | - | - |
Sale (Purchase) of Intangibles | -209.41 | -62.7 | - | 136.36 | - | -172.52 |
Investment in Securities | -5,455 | -7,027 | -14,214 | -28,500 | -7,286 | -1,984 |
Other Investing Activities | -9.5 | -28.43 | 7.4 | 458.98 | 634.79 | -6,675 |
Investing Cash Flow | -4,699 | -6,148 | -17,751 | 10,276 | -6,624 | -7,597 |
Long-Term Debt Issued | - | - | - | - | - | 22,649 |
Total Debt Issued | - | - | - | - | - | 22,649 |
Long-Term Debt Repaid | - | -772.9 | -695.49 | -1,172 | -257.28 | -419.54 |
Total Debt Repaid | -786.21 | -772.9 | -695.49 | -1,172 | -257.28 | -419.54 |
Net Debt Issued (Repaid) | -786.21 | -772.9 | -695.49 | -1,172 | -257.28 | 22,229 |
Issuance of Common Stock | - | - | - | - | - | 9,001 |
Repurchase of Common Stock | - | - | - | - | - | -323.35 |
Other Financing Activities | - | - | 50.81 | -14.95 | -9.13 | -0 |
Financing Cash Flow | -786.21 | -772.9 | -644.68 | -1,187 | -266.41 | 30,907 |
Foreign Exchange Rate Adjustments | 566.4 | -244.5 | 503.86 | - | - | - |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | - | -0 |
Net Cash Flow | 3,019 | 1,031 | -18,011 | 7,625 | -3,107 | 22,191 |
Free Cash Flow | 7,910 | 8,160 | -190.34 | -1,471 | 3,768 | -1,213 |
Free Cash Flow Margin | 9.57% | 9.35% | -0.25% | -5.38% | 12.11% | -13.91% |
Free Cash Flow Per Share | 338.71 | 353.27 | -8.27 | -71.98 | 207.05 | -78.51 |
Cash Interest Paid | 49.63 | 53.95 | 78.02 | 72.52 | 432.11 | 826.62 |
Cash Income Tax Paid | 178.52 | 194.52 | 5.35 | 322.7 | -102.46 | 83.37 |
Levered Free Cash Flow | 7,459 | 7,150 | -3,034 | -4,900 | 2,378 | - |
Unlevered Free Cash Flow | 7,490 | 7,184 | -2,985 | -4,862 | 3,133 | - |
Change in Working Capital | 4,630 | 3,481 | -4,792 | -1,731 | 3,231 | 1,976 |